MET binding affinity and kinetics measured by TR-FRET probe competition
Biochemical assay · Isolated, biotinylated human MET cytoplasmic domain (residues 956–1390; UniProt P08581). MET concentration 0.2 nM; fluorescent Kinase Tracer 236 concentration 50 nM. [1]
AMG-208 bound MET in equilibrium and kinetic probe-competition assays. The kinetic KD was 2.081 × 10^-9 M. Equilibrium IC50 and KD values were flagged ≈ by the authors, indicating CV>100% or n=1 because one run was not evaluable; the specific reason for this row was not distinguished. These binding endpoints do not establish cellular potency or an effective treatment concentration.
| Endpoint | Reported result | Reference |
|---|---|---|
| MET binding affinity from kinetic probe competition | KD,kin 2.081 × 10^-9 M | [1] |
| Association of AMG-208 with MET | kon 4.3395 × 10^6 M^-1 s^-1 | [1] |
| Dissociation of AMG-208 from MET | koff 8.221 × 10^-3 s^-1 | [1] |
| Displacement of fluorescent probe from MET at equilibrium | IC50 (probe displacement) ≈7.28855 × 10^-10 M | [1] |
| MET equilibrium binding affinity estimated from probe displacement | KD,eq ≈5.0320329721362235 × 10^-10 M | [1] |
Literature-Reported Treatment Conditions
- Treatment concentration
- Kinetic assay: four concentrations spanning 2.5–2500 nM (10-fold dilution). Equilibrium assay: 11-point, 3.5-fold dilution spanning either 72.5 pM–20 µM or 7.25 pM–2 µM; the AMG-208-specific range is not identified.
- Exposure duration
- Equilibrium incubation >1 h. Kinetic acquisition settings: 40 cycles at 10-s intervals for MET.
- Method
- TR-FRET probe competition at room temperature. High control: probe and kinase without test compound; low/background control: probe and streptavidin-terbium without kinase. Equilibrium curves used a four-parameter fit; kinetic traces used a global Motulsky–Mahan fit.
- Vehicle
- DMSO; final 1% in equilibrium assays. Kinetic assays used 100 nL of DMSO stock in a nominal 10 µL assay (1% by the stated volumes); control wells received DMSO.
- Reported limits
- Exact AMG-208 equilibrium concentration range, compound-specific valid replicate count and error estimates are not tabulated. General methods specify at least two independent experiments with two duplicates each. The ≈ flag on equilibrium results overrides any assumption of a precise replicate count.
Methods and source locations
Compound reported in the paper: AMG-208; Compound label in the paper: AMG-208; CAS 1002304-34-8 (Table S4)
Supports biochemical binding of the identity-matched molecule to isolated MET. Does not establish Adooq batch performance, cellular activity, animal efficacy, or formulation equivalence.
Supplementary spreadsheet ja8b08048_si_002.xlsx, Tabelle1, row 7148 (Met / AMG-208); headers row 9 and qualification notes rows 2–7; Supplementary Information ja8b08048_si_001.pdf, pp. S2, S4–S10, Table S1 p. S34, Table S2 p. S35, Table S4 p. S37
MET binding affinity from kinetic probe competition: TR-FRET kinetic probe competition; kinetic affinity derived from koff/kon. The tabulated KD is retained without recomputing it from the separately tabulated rate constants. — Supplementary spreadsheet ja8b08048_si_002.xlsx, Tabelle1, row 7148 (Met / AMG-208); headers row 9 and qualification notes rows 2–7; cells G7148:H7148; Supplementary Information ja8b08048_si_001.pdf, pp. S2, S4–S10, Table S1 p. S34, Table S2 p. S35, Table S4 p. S37
Association of AMG-208 with MET: Kinetic probe competition; global Motulsky–Mahan fit. — Supplementary spreadsheet ja8b08048_si_002.xlsx, Tabelle1, row 7148 (Met / AMG-208); headers row 9 and qualification notes rows 2–7; cells K7148:L7148; Supplementary Information ja8b08048_si_001.pdf, pp. S2, S4–S10, Table S1 p. S34, Table S2 p. S35, Table S4 p. S37
Dissociation of AMG-208 from MET: Kinetic probe competition; global Motulsky–Mahan fit. — Supplementary spreadsheet ja8b08048_si_002.xlsx, Tabelle1, row 7148 (Met / AMG-208); headers row 9 and qualification notes rows 2–7; cells M7148:N7148; Supplementary Information ja8b08048_si_001.pdf, pp. S2, S4–S10, Table S1 p. S34, Table S2 p. S35, Table S4 p. S37
Displacement of fluorescent probe from MET at equilibrium: Equilibrium TR-FRET probe competition; four-parameter dose-response fit. This is not a catalytic kinase-activity IC50. — Supplementary spreadsheet ja8b08048_si_002.xlsx, Tabelle1, row 7148 (Met / AMG-208); headers row 9 and qualification notes rows 2–7; cells C7148:D7148; Supplementary Information ja8b08048_si_001.pdf, pp. S2, S4–S10, Table S1 p. S34, Table S2 p. S35, Table S4 p. S37
MET equilibrium binding affinity estimated from probe displacement: Cheng–Prusoff conversion of equilibrium probe-displacement IC50. The ≈ qualification is retained. — Supplementary spreadsheet ja8b08048_si_002.xlsx, Tabelle1, row 7148 (Met / AMG-208); headers row 9 and qualification notes rows 2–7; cells E7148:F7148; Supplementary Information ja8b08048_si_001.pdf, pp. S2, S4–S10, Table S1 p. S34, Table S2 p. S35, Table S4 p. S37